Groupe d'Etude en Oncologie du Quebec

Titre	Long Term Follow-Up of Participants Exposed to GSK3377794 (NY-ESO-1c259 T), a Genetically Engineered NY-ESO-1 Specific T Cell Receptor
Protocole ID	GSK 208750
ClinicalTrials.gov ID	NCT03391778
Type(s) de cancer	Autre
Phase	Autres
Institution	CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
Ville	Montréal
Investigateur(trice) principal(e)	Dr Simon Turcotte
Coordonnateur(trice)	Marie Martin 514-890-8000 poste 30737
Statut	Fermé
Critètes d'éligibilité	Subjects who have received at least one dose of GSK3377794 in the interventional study. Subjects who have either completed the interventional study or have withdrawn from it. Male or Female subjects. Capable of giving signed informed consent prior to the study participation.
Critètes d'exclusion	None

Groupe d'étude en oncologie du Québec